The Sandino Group will manage a direct response TV campaign promoting PreHistin, an anti-allergy product. Terms of the deal, which was inked with PreHistin marketer Cobaliso Corp., were not revealed.
The direct-to-consumer television spots are scheduled to roll out in San Antonio and Austin, Texas, in March, and are timed to coincide with the mountain cedar allergy session.
The initial launch will be followed by a targeted regional and national campaign which tracks the spring, summer and fall allergy seasons throughout the United States.
James Sandino, CEO of The Sandino Group, has worked with a variety of large and small prescription and over the counter health care companies, including Pfizer, GlaxoSmithKline, Merck, Roche and Novartis.
Network
